"Revolutionizing Care: A Hospital's Mission to Lower Multiple Myeloma Treatment Costs"

Cellular immunotherapy offers new hope for multiple myeloma patients, yet its $500,000 cost limits accessibility. A clinical trial at Ben Taub Hospital aims to prove its effectiveness, led by Doctors Mims and Lulla. Their innovative CAR T-cell therapy shows promise, potentially paving the way for broader access to life-saving treatments.